Literature DB >> 23624121

Mechanism of insulin production in canine bone marrow derived mesenchymal stem cells.

Hiroshi Takemitsu1, Dongwei Zhao, Shingo Ishikawa, Masaki Michishita, Toshiro Arai, Ichiro Yamamoto.   

Abstract

Insulin is a critical hormone in the regulation of blood glucose levels and is produced exclusively by pancreatic islet beta-cells. Insulin deficiency due to reduced pancreatic islet beta-cell number underlies the progression of diabetes mellitus, prompting efforts to develop beta-cell replacement therapies. However, precise information on beta-cell replacement and differentiation in canines is limited. In this study, we established insulin-producing cells from bone marrow derived mesenchymal stem cells transiently expressing canine pancreatic and duodenal homeobox 1 (Pdx1), beta cell transactivator 2 (Beta2) and V-maf avian musculoaponeurotic fibrosarcoma oncogene homolog A (Mafa) using a gene transfer technique. Real-time PCR analysis revealed an increase in insulin mRNA expression of transfected cells. And ELISA revealed that insulin protein expressed was detected in cytoplasmic fraction. Insulin immunostaining analysis was performed and observed in cytoplasmic fraction. These results suggest that co-transfection of Pdx1, Beta2 and Mafa induce insulin production in canine BMSCs. Our findings provide a clue to basic research into the mechanisms underlying insulin production in the canines.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23624121     DOI: 10.1016/j.ygcen.2013.04.009

Source DB:  PubMed          Journal:  Gen Comp Endocrinol        ISSN: 0016-6480            Impact factor:   2.822


  4 in total

1.  Use of adipose-derived mesenchymal stem cells in keratoconjunctivitis sicca in a canine model.

Authors:  Antonio J Villatoro; Viviana Fernández; Silvia Claros; Gustavo A Rico-Llanos; José Becerra; José A Andrades
Journal:  Biomed Res Int       Date:  2015-02-23       Impact factor: 3.411

2.  Insulin-Producing Cells Differentiated from Human Bone Marrow Mesenchymal Stem Cells In Vitro Ameliorate Streptozotocin-Induced Diabetic Hyperglycemia.

Authors:  Ying Xin; Xin Jiang; Yishu Wang; Xuejin Su; Meiyu Sun; Lihong Zhang; Yi Tan; Kupper A Wintergerst; Yan Li; Yulin Li
Journal:  PLoS One       Date:  2016-01-12       Impact factor: 3.240

Review 3.  From Mesenchymal Stromal/Stem Cells to Insulin-Producing Cells: Progress and Challenges.

Authors:  Mohamed A Ghoneim; Ayman F Refaie; Batoul L Elbassiouny; Mahmoud M Gabr; Mahmoud M Zakaria
Journal:  Stem Cell Rev Rep       Date:  2020-12       Impact factor: 5.739

4.  Tailored generation of insulin producing cells from canine mesenchymal stem cells derived from bone marrow and adipose tissue.

Authors:  Watchareewan Rodprasert; Sirirat Nantavisai; Koranis Pathanachai; Prasit Pavasant; Thanaphum Osathanon; Chenphop Sawangmake
Journal:  Sci Rep       Date:  2021-06-11       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.